Nivalis Therapeutics, Inc. (NASDAQ:NVLS) reported a net loss of $5.9 million, compared to a net loss of $4.2 million in the same quarter last year. The increased loss was the result of the initiation of the Phase 1b clinical trial, which began in the first quarter of 2015, and related development costs for N91115. Nivalis Therapeutics, Inc. (NASDAQ:NVLS) belongs to Healthcare sector. Its weekly performance is -3.14%. On last trading day company shares ended up $17.30. Nivalis Therapeutics, Inc. (NASDAQ:NVLS) distance from 50-day simple moving average (SMA50) is 5.18%.
On 31st July, NantKwest, Inc. (NASDAQ: NK), announced the closing of its initial public offering of 9,531,200 shares of common stock at a price to the public of $25.00 per share, which included 1,243,200 shares sold pursuant to the exercise in full by the underwriters of the offering of their option to purchase additional shares. NantKwest estimates the net proceeds from the offering were approximately $222.5 million after deducting the underwriting discounts and commissions and other offering expenses. NantKwest (NASDAQ:NK) shares moved up 8.46% in last trading session and ended the day at $30.00.
Evolving Systems Inc. (NASDAQ:EVOL) reported Revenue decreased 24% to $6.1 million from $7.9 million in the same quarter last year. License and services revenue was $3.6 million versus $5.2 million last year. Customer support revenue was $2.5 million versus $2.8 million last year. On 04 August, Evolving Systems Inc. (NASDAQ:EVOL) shares decreased -0.82% and was closed at $8.42. EVOL EPS growth in last 5 year was 73.40%. Evolving Systems Inc. (NASDAQ:EVOL) year to date (YTD) performance is -10.14%.
inTEST Corporation (NYSE MKT: INTT), announced that the company will release financial results for the second quarter 2015 on Wednesday, August 5, 2015 after the market close. inTEST Corp. (NYSEMKT:INTT) ended the last trading day at $4.18. Company weekly volatility is calculated as 1.92% and price to cash ratio as 1.96. inTEST Corp. (NYSEMKT:INTT) showed a weekly performance of -1.18%.
Coach, Inc. (NYSE:COH) posted quarterly net income of $11.7 million, or $0.04 per share, versus $75.2 million, or $0.27 per share, in the year-ago quarter. Excluding items, the company’s earnings came in at $0.31 per share. Its sales declined to $1.00 billion from $1.14 billion. However, analysts were expecting earnings of $0.29 per share on revenue of $973 million. Coach, Inc. (NYSE:COH) shares advanced 3.22% in last trading session and ended the day at $31.41. COH Gross Margin is 69.60% and its return on assets is 12.10%. Coach, Inc. (NYSE:COH) quarterly performance is -16.71%.